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ABSTRACT 
NZB, NZW and NZB/NZW mice were pretreated with nonaggregated bovine 
gamma globulin (BGG) to produce tolerance to this protein measured as a secondary 
response at 6 weeks of age when autoimmune disease was absent and at 9 months when 
disease was active. The young NZB and NZB/NZW hybrids were relatively resistant 
to the development of tolerance when compared with CBA and Swiss ICR control 
animals. However, 9 month old NZB mice were made tolerant easily. The old NZB/ 
NZW hybrids showed a poor antibody response to immunization with BGG so that 
specific immunosuppression could not be unequivocally estabbshed. The NZW mice 
could not be made tolerant at any age. Spleen cells from old NZB mice could not 
initiate a graft versus host reaction, but spleen cells from young NZB and old NZW 
mice showed a vigorous response. Reticuloendothelial (RE) function as measured by 
clearance of colloidal carbon was identical in all the New Zealand and control mice, 
except in the NZB strain which exhibited increased RE activity. Nonaggregated BGG 
was cleared from the circulation 2 to 3 times more rapidly in all three New Zealand 
strains than in CBA and Swiss ICR controls. RE function and clearance of non-
aggregated BGG in New Zealand mice could not be correlated with the immunologic 
reactivity of these animals to BGG. 
New Zealand mice of the NZB and NZB/ 
NZW strains are afflicted by a genetically deter-
mined autoimmune disease which is character-
ized by Coombs' positive hemolytic anemia, LE 
cell phenomena and lethal glomerulonephritis. 
This paper reports experiments which evaluated 
immunologic and reticuloendothelial (RE) func-
tions in the two parent strains NZB and NZW 
and their F1 hybrid, NZB/ NZW (B/W). The 
immunologic studies include the ability of adult 
New Zealand animals to develop tolerance to a 
soluble protein, bovine gamma globulin (BGG) 
and the abibty of splenic mononuclear cells from 
NZB and NZW mice to initiate a graft versus 
host reaction in F1 B/W hybrids. If autoimmune 
disease is primarily caused by a los of self-toler-
ance, then these animals might not be able to 
develop tolerance in adult life to foreign proteins 
in the same way that normal mice can. The 
Simonsen assay (graft versus host reactivity) 
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was carried out to test one aspect of cellular 
hyper en itivity in these animals. The tolerance 
induction experiments were further evaluated by 
determining the catabolic fate of BGG in New 
Zealand mice and control animal~ and by mea-
uring RE function in these same animals. w1ss 
ICR and CBA mice served as controls. 
MATERIAL AND METHODS 
Animals. The source of our colony of NZB, 
ZW and B/ \iV mice and their care have been 
described previously ( 1). The NZB strain is cur-
rently in the 85th and the ~ZW in the 43rd 
g nerations. wiss albino ICR mice (specific 
pathogen free) were obtained both from Charles 
River Farms, North Wilmington, Ma sachusetts 
and from the breeding colony in the Division of 
Animal Care at Yale University. CBA mice were 
obtained from J ackson Laboratories, Bar Harbor, 
Maine. 
Induction of tolerar~ce. The ability to develop 
tolerance to BGG wa studied in NZB and F1 
B/ W mice at 6 weeks when autoimmune disease is 
not _detectable and at 9 to 12 months when the 
illness is present. NZW and Swiss ICR mice, 6 
weeks and 9 to 12 months old were similarly 
valuated. Only 6 week old CBA animals were 
available for tudy. The method of Claman was 
used (2). BGG (Pentex) was dissolved in 0.9% 
saline in a concentration of 25 mg/ ml and ultra-
centrifuged in a Beckman Model L machjue at 
318 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
60,000 G (center of tube) for 40 minutes. Protein 
content of the supernatant was determined by UV 
absorption at 280 mp. in a Carey recording spectro-
photometer. The pellet contained 4% of the BGG. 
The supernatant which contained nonaggregated 
BGG was stabilized by adding 0.1 ml of normal 
mouse serum to each 16 ml of BGG supernatant. 
On day 0, mice to be made tolerant were injected 
i.p. with 1.9 mg (0.08 ml) of soluble BGG. Con-
trol animals received an identical amount of 
normal saline. On day 12, all mice were sensitized 
by the subcutaneous injection of 1.5 mg of non-
centrifuged BGG in complete Freund's adj uvant. 
On day 40, all mice were boosted intradermally 
with 200 p.g BGG in saline. On day 49, all animals 
were bled and hemagglutination titers to BGG 
were determined by the tanned red cell technique 
(3) in a microtitration apparatus (Autotiter serial 
dilution machine, Astec Inc., Orange, Connecticut). 
The concentration of BGG used to coat the tanned 
sheep red cells was 0.5 mg/ml. 
The BGG for coating the red cells was purified 
by the DEAE cellulose batch technique of Stan-
worth to remove the 'YA globulin contaminant in 
BGG ( 4). Virtually all of the 'YA globulin was 
removed as judged by gel diffusion studies in which 
a strong antiserum against 'YA globulin was tested 
against the purified BGG (antiserum furnished by 
Dr. B. Waksman). Hemagglutination titers were 3 
to 4 dilutions less with purified BGG coated cells 
than with those coated with the nonpurified BGG. 
Simonsen Assay. Graft versus host (GVH) reac-
tivity was assessed in 2 to 3 and 9 to 12 month old 
NZB and NZW mice. Two groups of old NZB 
mice were studied. One exhibited the usual 
Coombs' positive hemolytic anemia but the other 
had neither a positive direct Coombs' test nor 
increased reticulocytosis. The spleens from the 
animals were cut and teased in Hanks' balanced 
salt solution and passed through a wire mesh to 
separate the cells. Mononuclear cells were counted 
in a hemocytometer. On day 0, 10 X 10° splenic 
mononuclear cells from a single donor were in-
jected i.p. into 3 or 4, 7 to 8 day old F1 B/ W 
mice. Littermates (3 to 4) were injected with saline 
and served as controls. On day 10, all mice were 
killed, their spleens weighed and the splenic index 
determined. 
p emc m ex = --"----=--S l . . d spleen wgt T I spleen wgt C 
body wgt T body wgt C ' 
where T refers to the test recipient and C, the con-
trol littermate recipient. The means of the ratios 
determined for each corresponding set of recipients 
and controls were used to determine the splenic 
index (5). Splenic enlargement is a measure of 
~VH reactivity. In our laboratory, the splenic 
mdex for transfer of syngeneic spleen cells within 
a given inbred strain is less than 1.3. 
RE function, clearance of colloidal carbon. The 
colloidal carbon (Pelikan ink, Cll/1431a, Gunther 
Wagner) was prepared as follows: The ink was 
centrifuged for 15 minutes at 5000 rpm. The super-
nate was dialyzed against distilled water overnight 
and the concentration of carbon was adjusted with 
distilled water to yield a concentration of 16 mg/ 
rnl. Gelatin was added at a concentration of 1%. 
The ink was kept at 4° C but was warmed to 37° C 
before use. A dose of 16 mg/100 grams body weight 
was injected via the tail veins of the mice. Each 
animal was bled from the retroorbital plexus at 3 
minute intervals with a 20 microliter disposable 
capillary pipette. The blood was hemolyzed in 1.1 
ml of 0.1 % Na2COs and the optical density was 
read at 600 mp. in a Bausch and Lomb Spectronic 
spectrophotometer. The phagocytic indices were 
calculated in the following manner (6): 
k = log (C1 - C2) 
h- t2 
a= W ·Vk 
Wls 
where k is the phagocytic index and C1 and C2, the 
concentrations of carbon in the blood at t imes t1 
and t2 respectively. The corrected phagocytic index, 
a: , is a measure of phagocytic activity per unit mass 
of RE tissue. W is the body weight, and Wls the 
combined weight of the liver and spleen in an 
individual animal. NZW, F1 B/W and Swiss ICR 
mice 2 to 3 and 9 to 12 months old were studied. 
NZB animals were studied in groups aged 2 to 3, 
5 to 6 and 9 to 12 months. 
Clearance of Jl31-labeled nonaggregated BGG. 
BGG was trace labeled with P31 (as Nai, Cam-
bridge Nuclear) according to the method of Thor-
becke and Benacerraf (7). Ten mg of BGG were 
labeled with 0.25 me NailSl, reductant free. After 
labeling, 1 p.g BGG had on the average 1500 cpm. 
The labeled BGG was ultracentrifuged in a manner 
identical to that performed in the tolerance induc-
tion experiments in order to remove aggregated 
BGG. The soluble BGG fraction was then injected 
i.p. or i.v. in a dose of 3 mg/100 grams body weight 
into NZB, F1 B/ W, NZW, CBA and Swiss ICR 
mice, 6 weeks and 9 months old. These animals had 
never been used experimentally. Beginning 48 
hours after the injection of labeled BGG, during 
the catabolic phase of antigen elimination, 50 
microliters of blood were removed at 24 hour in-
tervals for 7 days from the retroorbital plexus by 
calibrated disposable capillary pipettes. The blood 
samples were saved and counted on the same day 
in a Picker spectroscaler scintillation counter. The 
percentage of radioactivity remaining in the blood 
daily was plotted an a semilogarithmic graph. The 
half time disappearance of radioactivity was cal-
culated from the resulting straight line for each 
animal. KI, 0.1% was placed in the animals' drink-
ing water for 3 days before, as well as during, these 
studies. 
The Wilcoxon rank sum test was used for the 
statistical evaluation of the data. 
RESULTS 
Tolerance induction to EGG. Table I shows 
the results of the tolerance induction experi-
ments. It was possible to suppress secondary 
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TABLE I 
Hemagglutination titers (Logz) to BGG 
Hemagglutination ti ters• 
Strain Age Mean 
titert 
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
- - - - - - - - - - - - - - -
B/W-Tt 6 wk 2 1 2 1 3 2 2 3 6.5 
B/W-C§ 6 wk 2 4 3 1 2 1 1 10 .3 
- - - - - - - - - - - - - -
B/W-T 9 mo 3 2 2 1 2 1 1 3.0 
B/W-C 9 mo 3 1 1 1 3 5 3 1 5.2 
- - - - - - - - - - - - -
NZB-T 6 wk 3 1 6 2 6.8 
NZB-C 6 wk 1 2 3 2 2 10.2 
- - - - - - - - - - - - -
NZB-T 9 mo 6 1 1 1 2.9 
NZB-C 9 mo 2 2 6 3 2 2 1 8.6 
- - - - - - - - - - - - -
NZW -T 6 wk 1 2 2 4 6 2 1 9.2 
NZW-C 6 wk 6 3 5 1 1 10.2 
- - - - - - - - - - - - -
NZW-T 9 mo 1 2 1 3 2 2 1 7.7 
NZW-C 9 mo 5 2 3 9.8 
- - - - - - - - - - - - - -
CBA-T 6 wk 3 4 3 5 4 1 1 3.6 
CBA-C 6 wk 2 3 4 4 1 3 1 4 8 .3 
- - - - - - - - - - - - -
ICR-T 6 wk 1 1 2 2 1 2 4.8 
ICR-C 6 wk 1 4 1 4 4 1 10.2 
- - - - - - - - - - - - -
I CR-T 9 mo 1 2 1 3 6 2 3 8.6 
ICR- 9 mo 1 2 6 1 2 10.0 
*Number of mice having individual (log2) titers. 
t Average (log2) titers by strain. 
t T represents animals pretreated with nonaggregated BGG. 
§ C repre ents nonpretreated controls. 
antibody response to BGG by 4 to 5 dilutions in 
6 week old wiss ICR and CBA mice. In com-
parison, 6 week old B/W and NZB mice were 
relatively resistant to the development of unres-
ponsivene . Only 5 of 16 B/ W and 3 of 12 NZB 
mice developed low titers to BGG. In contrast, 6 
of 9 old NZB animals showed suppre ion of 
antibody formation with a titer of zero. Control 
NZB mice of this age, formed high antibody 
titers to BGG. 
The control 9 month old B/W mice showed a 
relatively poor antibody response to BGG 
(Table I). Although the pretreated 9 month old 
B/W mice had significantly lower average titers 
than their controls (p < 0.05), the presence of 
specific immunosuppression could not be unequi-
vocally established. 
NZW mice of both age groups were resistant 
to the induction of tolerance. Nine month old 
Swiss ICR mice could not be made unresponsive 
to BGG in 3 separate experiments, in contrast to 
the ease of suppression induced in 6 week old 
Swiss animals. 
The striking findings in thi et of experiments 
were the poor antibody response of BGG by the 
old B/W mice, and the greater percentage of 
instances of suppressed antibody formation 
among old N ZB mice with active autoimmune 
disease than among healthy 6 week old NZB 
animals (9/12 vs. 3/9 respectively). 
Simonsen assay. Figure 1 shows the results of 
the e experiments. Each point represents the 
splenic index determined for the cells of a single 
donor. The control values for syngeneic splenic 
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Fro. 1. Simonsen Assay. Each point represents the splenic index determined for cells from 
a single donor. 
cell transfers (old NZB to young NZB, and old 
NZW to young NZW mice) are 1.3 or less in 
this laboratory. Young NZB spleen cells showed 
vigorous reactivity when introduced into wean-
ling F1 B/W mice. However, the splenic mononu-
clear cells of virtually all 9 to 12 month old 
NZB mice showed a lack of GVH reactivity, 
irrespective of whether or not autoimmune hem-
olytic anemia was present. The splenic cells from 
9 to 12 month old NZW mice which do not have 
significant autoimmune disea e bowed vigorous 
G VH reactivity. 
Clearance of F 1-labeled nonaggregated BGG. 
The intraperitoneal and intravenous routes of 
administration of BGG produced identical re-
sults. The catabolic phase of elimination of the 
nonaggregated ! 131-BGG was faster in all 3 New 
Zealand strains than in the CBA and ICR con-
trols (Figure 2). The half-time disappearance of 
radioactivity from the blood was approximately 
160 hours in both young and old control Swiss 
ICR and CBA mice. However, in young New 
Zealand animals, the average half-time was 100 
hours and in old mice of the same strains, it was 
50 hours. There was no correlation between the 
degree of immunologic unresponsiveness to BGG 
in these various strains and the corresponding 
clearance rates of the nonaggregated BGG. Old 
NZB mice, which as a group became unrespon-
sive to BGG most easily, displayed the same 
average half-time clearance as NZW mice who 
could not be made unresponsive. 
Clearance of colloidal carbon. The phagocytic 
indices (k) for carbon in the various groups of 
mice are shown in Table II. There were no sta-
tistically significant differences between the 
phagocytic indices of the New Zealand mice and 
control strains in the various age groups except 
for the old NZB animals which did phagocytize 
carbon particles more actively than the other 
strains. The phagocytic indices increased with 
age in the NZB strain and were correlated with 
the development of hemolytic anemia and the 
recognized decreased red cell survival in the old 
NZB animals (8) . In NZB mice, 2 to 3 months 
old, k = 0.029; at 5 to 6 months, k = 0.036; 
and at 12 months, k = 0.042. 
The corrected phagocytic index a, which 
measures phagocytic activity per unit mass of 
RE tissue gave somewhat different results 
(Table II). The RE system in young NZB mice 
is significantly more active than in the other 
New Zealand and control animals (p < 0.01) . 
Old NZB mice most likely also have a more 
active RE system than the other mice. The 
value of a in the old NZB mice is falsely low 
because the increase in spleen weight in old NZB 
mice, which is inversely related to a, is produced 
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FIG. 2. Half-time clearance of P31-BGG 
clearance rate of a single animal. 
chiefly by secondary hematopoiesis rather than 
by lymphoid hyperplasia. Noteworthy is the ob-
servation that the RE system in B/W mice is 
not significantly more active than the RE sys-
tem in NZW, Swiss ICR or CBA animals as 
measured by a. The activity of the RE system 
in B/W mice does not increase with age al-
though it does in the NZW strain (p < 0.01). 
There was no correlation in the New Zealand 
and control strains between the phagocytic in-
dices for carbon particles, the clearance rates of 
nonaggregated 1131-BGG and the capacity to de-
velop unresponsiveness to BGG. 
DISCUSSION 
Genetic factors play a decisive role in deter-
mining the manifestations of autoimmune dis-
ease among the different strains of New Zealand 
mice (1, 9). The NZB mouse exhibits primarily 
a Coombs' positive hemolytic anemia, and in 
about 5% of animals, LE cell phenomena and 
serum antinuclear factor (ANF). The NZW ani-
mal shows weakly positive Coombs' tests and 
rarely a positive test for serum ANF after one 
year of age. Clinical autoimmune disease does 
99 46 
• 
• 
• I 
• 
•• 
• 
• 
NZW 
2 10 - 12 
from the blood. 
Strain Age (months) 
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TABLE II 
Phagocytic Indices 
Number K 
tested C:Mean ± S. D.) 
12 .029 ± .001 
17 .042 ± .002 
12 .032 ± .001 
12 .034 ± .003 
12 .031 ± .005 
10 .026 ± .002 
15 .038 ± .007 
11 .029 ± .003 
a 
(Mean ±S.D.) 
6.80 ± 1.41* 
6.07 ± 1.30t 
5.82 ± 0.96 
5.91 ± 1.25 
4.55 ± 0.65t 
5.66 ± 0.47t 
5.20 ± 0.49 
5.09 ± 2.63 
* a is significantly higher in young NZB mice 
than in other young mice (p < 0.01). 
t a of old NZB is probably significantly higher 
than a in other old mice. See discussion. 
t a increases significantly with age in NZW 
strain (p < 0.01). 
not develop. The autoimmune illness that devel-
ops in the F1 B/W hybrid derived from the 
NZB and NZW strains is characterized predomi-
nantly by LE cell phenomena and serum ANF; 
Coombs' positive hemolytic anemia is a minor 
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facet of the clinical disease. The F1 B/W hybrid 
is the sickest of all the New Zealand strains and 
usually dies by one year of age from renal dis-
ease. The NZB mouse lives for 18 to 24 months, 
and the NZW animals for even longer periods. 
Although the histology of the renal lesions in the 
NZB and NZW mice is similar to those of the 
B/W hybrids by conventional light microscopy, 
the renal disease does not behave in a similarly 
lethal fashion. 
If autoimmune disease were related to a loss 
of self tolerance, it is reasonable to expect that 
the New Zealand mice might not be able to 
develop tolerance to foreign proteins in a fashion 
identical to that observed in normal adult mice. 
Further, because there are such striking dif-
ferences in the manifestations of autoimmune 
disease among the 3 New Zealand strains, immu-
nologic reactivity might vary among them as 
well. 
Our data show that NZB mice are relatively 
resistant to the development of tolerance to 
BGG, as measured by secondary response, at 6 
weeks of age when they are healthy, but that 
they can be made unresponsive easily at 9 
months when autoimmune disease is active. 
These findings in 6 week old NZB mice are 
identical to the observations of Staples and 
Talal (10). However, the latter investigators did 
not include old NZB animal in their studies. In 
sub equent experimen , Staples and Talal found 
that newborn NZB and B/W mice could be ren-
dered completely tolerant to BGG for up to 41 
day after which tolerance was lost (11). Edel-
son and Braverman have confirmed these 
findings (12). 
Ther exi ts, therefore, a peculiar triphasic 
immunologic response in NZB mice. Tolerance 
to BGG can develop easily at birth but is lost 
within 4 to 6 weeks. Resistance to the develop-
ment of tolerance to BGG appears in early adult 
life when autoimmune disease i not yet detecta-
ble. The ability to develop tolerance then reap-
pears when autoimmune disea e becomes evi-
dent. It remains to be established whether this 
phenomenon in NZB mice can be produced by 
other soluble protein antigens or whether it is a 
unique re ponse to BGG. 
Our 6 week old B/W mice were also rela-
tively resistant to the development of tolerance 
to BGG. It is not clear whether this triphasic 
response to BGG is also operative in B/W hy-
brids. It was not possible to determine with cer-
tainty whether specific immunosuppression to 
BGG had occurred in old B/W mice because of 
the low titers in the control B/W animals, even 
though there was a statistically significant dif-
ference between the titers in the 2 groups of 
animals (p < 0.05). 
Bovine serum albumin (BSA) has been used 
by 3 groups of workers to induce low dose toler-
ance in adult New Zealand mice. In the study 
by Weir et al., antibody response was evaluated 
in 1 to 5 month old NZB animals by determining 
antigen binding capacities (13). Although NZB . 
animals as a group were relatively resistant to 
the induction of tolerance when compared with 
CBA controls, 50% of NZB mice showed partial 
unresponsiveness to BSA when compared with 
nonpretreated NZB controls. The values of the 
antigen binding capacities suggested that NZB 
mice were immunologically hyperreactive. 
Theis et al. assessed low dose tolerance to BSA 
in all 3 New Zealand strains by determining 
hemagglutination titers (14). Eighty percent of 
2 to 6 month old NZB and NZW mice were 
made unresponsive to BSA in a fashion identical 
to that ob erved in control CAF1 animals. Non-
pretreated control New Zealand mice developed 
lower antibody titers to BSA than the CAF1 
controls. The control B/W animals had such low 
titers that it was not possible to determine 
whether specific immunosuppression had oc-
curred in the pretreated B/W mice. Theis et al. 
concluded that hyporeactivity to BSA was char-
acteristic of their New Zealand mice. 
Salomon and Benveniste studied the immune 
response to BSA in 4Yz and 9 month old B/W 
mice (15). They observed that the older animals 
produced antibody to BSA more slowly than the 
younger ones during the first 12 days after im-
munization, but that by 24 days both groups 
had similar titers. 
Warner and Wistar were unable to find any 
differences in immunologic reactivity between 
New Zealand mice in their colony and control 
strains (16). Except for the 9 month old B/W 
animals, the final hemagglutination titers to 
BGG in our NZB, NZ\V and young B/W mice 
were not significantly different from those in 
Swiss ICR and CBA controls. The problem of 
immunologic hyperreactivity versus hyporeac-
tivity in New Zealand mice remains unresolved. 
The weak immune response to BGG in our old 
B/W hybrids is analogous to the findings for 
BSA reported by Theis et al. (14) and Salomon 
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and Benveniste (15) in their B/W mice. Although 
antigenic competition has been offered as an ex-
planation for this observation (15), uremia 
which develops at this age could account for the 
poor antibody response. 
The NZW mice in our colony could not be 
made tolerant to BGG at any age. taples and 
Talal also observed that the NZW mice were 
relatively resistant to tolerance induction to 
BGG (10). The 9 month old Swiss ICR control 
mice were also resistant to the induction of tol-
erance, but at 6 weeks unresponsiveness was 
readily produced. 
The catabolic phase of clearance of nonaggre-
gated 1131-BGG was tudied in the 3 New Zea-
land strains in order to find out if there were 
differences that could be correlated with the di-
verse immunologic reaction patterns observed in 
the BGG experiments. The studies of Frei et al. 
indicated that phagocytosis of antigen was im-
portant in the induction of the primary immune 
response in the rabbit ( 17). If these observa-
t ions were also valid for mice, then one might 
have expected to find a difference in the clear-
ance rates of the tolerogenic nonaggregated 
BGG among the different New Zealand mice. 
The strains that developed tolerance might be 
expected to have a slower clearance rate than 
those who were re istant to tolerance induction. 
Our data, however, indicate that the clearance 
rates were identical in the 3 New Zealand strains 
at comparable ages and that these rates could 
not be correlated with antibody production or 
suppression. The studies on RE function using 
colloidal carbon also could not be correlated 
\vith antibody production or suppression. 
Wochner has published data on patients with 
a variety of connective di orders that may be 
relevant to the clearance tudie of EGG in New 
Zealand mice (18). He found that patients with 
SLE, rheumatoid arthriti , polymyo itis and 
vasculitis have a catabolic rate for IgG that is 
twice normal. This increa ed catabolism could 
not be explained by any of the known factors 
that control the metabolism of IgG in man and 
animal . The association of this metabolic abnor-
mality with a number of diverse connective ti -
sue disorders in man is analogous to the acceler-
ated clearance rate of BGG in the 3 New Zea-
land mice which also show 3 dissimilar patterns 
of autoimmune disease. W ochner's study sug-
gests that increased catabolism of IgG may be a 
fundamental abnormality in a variety of human 
connective tissue disorders. 
The results of the studies on G VH reactivity 
confirm the findings of Stutman et al. (19). The 
splenic mononuclear cells from old NZB mice 
cannot initiate a GVH reaction in the F1 B/W 
hybrid. These current studies extend those of 
Stutman et al. by showing that the inability of 
splenic cells to initiate a GVH reaction is not 
necessarily correlated with the presence of au-
toimmune disease in the NZB donor. Splenic 
mononuclear cells from old NZB mice in whom 
autoimmune hemolytic anemia was not present 
were similarly unable to initiate GVH reactivity 
in B/W hybrids. Spleen cells from NZW mice of 
comparable age showed a vigorous GVH reac-
tion. The immunodepression of the GVH reac-
tion stands in contrast to the good antibody 
response to BGG and BSA in old NZB animals. 
These comparative immunologic and RE func-
tion studies have revealed 2 patterns of response 
that may be helpful in our understanding of 
autoimmune disease: The triphasic response to 
tolerance induction in NZB mice and a possibly 
increa ed catabolism of gamma globulin in all 3 
New Zealand strains. 
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